Position in RPRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$28,226,795
+$8,904,284 QoQ
Shares Held
588,426
+17.7% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DANSKE BANK A/S holds $231,483,974 across 62 Biotechnology names. RPRX ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
107,220 | $82,842,459 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
153,006 | $68,323,298 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
588,426 | $28,226,795 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
65,955 | $21,822,529 | |
| 5 | INSM |
INSMED Inc
|
111,058 | $18,160,204 | |
| 6 | INCY |
Incyte Corp
|
77,085 | $7,255,239 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
44,900 | $4,366,525 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,000 | $169,470 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,226,795 | 588,426 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $19,322,511 | 500,065 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $17,134,261 | 485,665 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $13,931,539 | 386,665 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $10,338,832 | 332,118 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $7,070,326 | 277,159 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $7,241,080 | 255,959 | Shares | Sole | 2026-03-18 | |
| 2024-06-30 | $6,311,896 | 239,359 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $7,071,927 | 232,859 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||